Tracking the CAR-T revolution:
Analysis of clinical trials of CAR-T and TCR therapies for the treatment of cancer
We look at all available FDA CAR-T/TCR clinical trials for the treatment of cancer, and analyze them with respect to different indications, targeted antigens, products, and originator locations.
Paying for Cures Virtual Conference
This one-day virtual conference will share research and solutions to the challenge of paying for high cost, durable and curative therapies. Attendees will leave understanding the estimated clinical trial pipeline of these types of therapies and their potential impact on the healthcare system.
Paying for Cures Toolkit updated with new material for patients and developers
Version 2 of the free online resource adds new sections for patients and developers, and provides new downloadable references, in addition to the interactive analysis and calculation tools. Open the Toolkit
NEW MEMBERSWe’re excited to welcome Kite and Roche/Genentech to the FoCUS Project and we look forward to their insights regarding precision financing solutions!
IN THE COMMUNITY Mark Trusheim was quoted in the AJMC article “CMS Issues Rules to Promote Value-Based Contracting, Pay for High-Cost Therapies in Medicaid“
Mark Trusheim, Danielle Rollman, and Shannon Baumann (bluebird bio) spoke in the BIO Digital session on Precision Financing for Durable and Curative Therapies moderated by John Glasspool
Mark Trusheim, Michael Sherman (Harvard Pilgrim Health Care), Annie Kennedy (Everylife Foundation), and Lauren Nelson (AveXis) spoke on the Alliance for Regenerative Medicine panel on June 2nd, Value-Based Payments 101 (Video)
Jane Barlow will be speaking at Product Launch for Cell and Gene Therapies conference September 23–24 in Boston; the Annual Alpha Stem Cell Clinic Symposium October 7–8 in Sacramento; and the NAMCP Value Based Care Council presentation October 9 in Las Vegas.
The next FoCUS Town Hall Meeting will be held online July 21. The next FoCUS Design Lab will be held online October 15-16. Both are by invitation only.